Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEXIUM Capsule Specific Clinical Experience Investigation (S-CEI) to Investigate Treatment Response to NEXIUM in Patients With Reflux Esophagitis (RE) - Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes

NCT02477475 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02477475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02477475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEXIUM Capsule Specific Clinical Experience Investigation (S-CEI) to Investigate Treatment Response to NEXIUM in Patients With Reflux Esophagitis (RE) - Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 7, 2015
Completion date
February 20, 2017
Enrollment
1,595 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

reflux esophagitis